Syensqo - Fourth Quarter and Full Year 2024 Results
27 February 2025 - 5:00PM
UK Regulatory
Syensqo - Fourth Quarter and Full Year 2024 Results
SYENSQO FOURTH QUARTER AND FULL YEAR 2024 RESULTS
5% YEAR-ON-YEAR EBITDA GROWTH IN Q4 &
STRONG CASH FLOW GENERATION IN A CHALLENGING MARKET
ENVIRONMENT
Q4 2024 Highlights
- Net sales of €1.6 billion increased by 2% year-on-year
organically, driven by higher volumes (+3%), partially offset by
lower pricing (-1%); On a sequential basis, pricing increased by 1%
compared to Q3 2024;
- Gross profit of €482 million was approximately flat
year-on-year including net pricing impact of €-26 million,
resulting in gross margin of 30.2%;
- Underlying EBITDA of €298 million increased by 5% year-on-year
organically, driven by growth in both the Materials and Consumer
& Resources segments; EBITDA margin of 18.6% increased by
approximately 60 basis points organically;
- Underlying net profit of €76 million;
- Operating cash flow of €345 million increased by 77%
year-on-year; Free cash flow of €159 million;
- Share buyback program: repurchased and cancelled 843K shares,
or €64 million
FY 2024 Highlights
- Net sales of €6.6 billion declined by 3% year-on-year
organically driven by lower pricing (-4%), partially offset by
higher volumes (+1%) with improved net sales momentum in the second
half; double digit growth in Composite Materials;
- Gross profit of €2.2 billion included net pricing impact of
€-97 million, resulting in gross margin of 33.8%;
- Underlying EBITDA of €1.4 billion, in-line with expectations;
EBITDA margin of 21.5%;
- Underlying net profit of €553 million;
- Operating cash flow of €841 million, with cash conversion of
82%1; Free cash flow 1 of €390 million;
- Balance sheet: net debt of €1.86 billion with leverage ratio of
1.3x;
- Increased shareholder returns: €300 million share buyback
program announced at the end of Q3; Dividend for 2024 of €1.62
(payout ratio of 31%) will be proposed to the 2025 Annual General
Meeting by the Board of Directors
Dr. Ilham Kadri, CEO
“2024 was a milestone year for Syensqo. With
our sharper focus and a deeper understanding of our customers’
needs, we now have more clarity around how we will accelerate our
innovation to outperform our markets and increase returns. We also
used our balance sheet strength to increase direct shareholder
returns, through the board’s proposed dividend payment as well as
the ongoing share buyback program.”
“Our Q4 performance saw us return to
year-on-year EBITDA growth, coupled with strong cash flow
generation. This was achieved against the backdrop of macroeconomic
softness and ongoing market uncertainties experienced across our
sector. In this context, we will remain focused on executing
initiatives in 2025 that we can control, accelerating cost actions
to support our profitability, further refining our disciplined
approach to capital allocation, and taking steps to unlock value.
Underpinned by our strong balance sheet, we will also continue to
balance cashflow generation and attractive growth investments with
shareholder returns.”
“2025 will also see us continue to assess
options to accelerate value creation, including through
divestments, to become an even more focused specialty company.
Having already determined that we will divest the Oil & Gas
business, we now plan to do the same with Aroma.”
“The Americas is Syensqo’s largest region,
representing more than 40% of our revenues and people, as well as
more than half of our industrial footprint. In addition, we expect
a major part of our future growth and investments to be in this
strategically important region. I am therefore pleased to share
that our Board of Directors has approved the exploration of a
potential dual listing in the US, in addition to Brussels, which
has the potential added benefits of expanding and enhancing our
investor base.”
2025 Outlook
For 2025, we expect macroeconomic and demand
uncertainty to continue across most of our end markets. Supported
by our strong balance sheet, we will focus on accelerating
initiatives that are within our control, increasing cost savings
and further focusing our investments to outperform our markets.
Growth is expected to be led by Composite
Materials, supported by strong underlying demand as well as our
diverse range of customer programs and applications. For Specialty
Polymers, we expect net sales to be approximately flat versus 2024,
with growth primarily driven by Healthcare and Food Packaging,
offset by the lower net sales in Electronics.
Overall, we expect flattish volumes in 2025.
This includes the combined impact of approximately €80 million in
Electronics, driven by a design change in a customer program, and
in Aerospace, as a result of strike action at a major customer and
its related impact on demand in the first half of the year.
In order to enhance our profitability in 2025
and beyond, we also plan to accelerate cost savings initiatives.
This is expected to both offset the inflationary impact on costs
during the year, and also deliver more than €200 million of run
rate savings by the end of 2026.
On a full year basis, our outlook is as
follows2:
- Underlying EBITDA of at least €1.4 billion
- Capital Expenditures to be approximately €600 million
- Free Cash Flow of approximately €400 million
The first quarter of 2025 is expected to deliver
the lowest quarterly EBITDA performance of 2025, given the expected
impacts mentioned above as well as lower year-on-year overall
demand. We therefore expect first quarter EBITDA to be at
approximately the same level as Q4 2024.
(€ million) |
Q4 2024 |
Q4 2023 |
Q3 2024 |
YoY change |
YoY organic |
QoQ change |
|
FY 2024 |
FY 2023 |
YoY change |
YoY organic |
Net sales |
1,598 |
1,577 |
1,633 |
1.3% |
1.6% |
-2.1% |
|
6,563 |
6,834 |
-4.0% |
-2.8% |
Gross profit |
482 |
485 |
572 |
-0.6% |
- |
-15.7% |
|
2,219 |
2,375 |
-6.6% |
- |
Gross profit margin |
30.2% |
30.8% |
35.0% |
-60 bps |
- |
-490 bps |
|
33.8% |
34.8% |
-90 bps |
- |
Underlying EBITDA |
298 |
294 |
374 |
1.2% |
5.1% |
-20.4% |
|
1,412 |
1,618 |
-12.7% |
-10.0% |
Underlying EBITDA margin |
18.6% |
18.7% |
22.9% |
0 bps |
60 bps |
-430 bps |
|
21.5% |
23.7% |
-220 bps |
-170 bps |
Operating cash flow |
345 |
195 |
210 |
77.1% |
- |
64.5% |
|
841 |
1,275 |
-34.0% |
- |
Op. cash flow excl. €167mn payment to NJDEP in Q2'24 |
345 |
195 |
210 |
77.1% |
- |
64.5% |
|
1,008 |
1,275 |
-20.9% |
- |
Free cash flow |
159 |
-35 |
27 |
n.m. |
- |
n.m. |
|
223 |
448 |
-50.2% |
- |
Free cash flow excl. €167mn payment to NJDEP in Q2'24 |
159 |
-35 |
27 |
n.m. |
- |
n.m. |
|
390 |
448 |
-12.9% |
- |
Cash conversion (LTM) |
71% |
85% |
69% |
n.m. |
- |
n.m. |
|
71% |
85% |
n.m. |
- |
Cash conversion (LTM) excl. €167mn payment to NJDEP in Q2'24 |
82% |
85% |
81% |
-260 bps |
- |
140 bps |
|
82% |
85% |
-260 bps |
- |
ROCE (LTM) |
7.9% |
10.6% |
8.1% |
-280 bps |
- |
-20 bps |
|
7.9% |
10.6% |
-280 bps |
- |
Register to the webcast scheduled at 14:00 CEST - Financial
report - Financial calendar
Contacts
Investors & Analysts
investor.relations@syensqo.com |
Media
media.relations@syensqo.com |
Sherief Bakr
Bisser Alexandrov
Loïc Flament |
+44 7920 575 989
+33 607 635 280
+32 478 69 74 20 |
Perrine Marchal
Laetitia Schreiber |
+32 478 32 62 72
+32 487 74 38 07 |
Safe harbor
This press release may contain forward-looking information.
Forward-looking statements describe expectations, plans,
strategies, goals, future events or intentions. The achievement of
forward-looking statements contained in this press release is
subject to risks and uncertainties relating to a number of factors,
including general economic factors, interest rate and foreign
currency exchange rate fluctuations, changing market conditions,
product competition, the nature of product development, impact of
acquisitions and divestitures, restructurings, products
withdrawals, regulatory approval processes, all-in scenario of
R&I projects and other unusual items. Consequently, actual
results or future events may differ materially from those expressed
or implied by such forward-looking statements. Should known or
unknown risks or uncertainties materialize, or should our
assumptions prove inaccurate, actual results could vary materially
from those anticipated. The Company undertakes no obligation to
publicly update or revise any forward-looking statements.
About Syensqo
Syensqo is a science company developing groundbreaking solutions
that enhance the way we live, work, travel and play. Inspired by
the scientific councils which Ernest Solvay initiated in 1911, we
bring great minds together to push the limits of science and
innovation for the benefit of our customers, with a diverse, global
team of more than 13,000 associates.
Our solutions contribute to safer, cleaner, and more sustainable
products found in homes, food and consumer goods, planes, cars,
batteries, smart devices and health care applications. Our
innovation power enables us to deliver on the ambition of a
circular economy and explore breakthrough technologies that advance
humanity.
2025 Calendar
- May 6, 2025: Annual General Meeting
- May 15, 2025: Q1 2025 results
- May 19, 2025: Proposed dividend payment date
- July 31, 2025: Q2 2025 results
- Nov 6, 2025: Q3 2025 results
Investor Relations Resources
- Earnings materials
- Strategy
- Share information
- Credit information
- Separation documents
- Webcasts, presentations and podcasts
- 2023 Annual Integrated Report
- Subscribe to our distribution list
- 2024Q4_PR_EN_FINAL
- 2024Q4_FinancialReport_EN_FINAL
Syensqo (TG:2NF)
Historical Stock Chart
From Jan 2025 to Feb 2025
Syensqo (TG:2NF)
Historical Stock Chart
From Feb 2024 to Feb 2025